期刊文献+

线粒体靶向递药系统的研究进展

Research Advance in Mitochondrial Targeting Drug Delivery System
下载PDF
导出
摘要 线粒体控制着细胞凋亡的激活系统。肿瘤细胞的多种特征,包括无限的增殖能力、对抑制生长信号的不敏感、受损的细胞凋亡机制等都与线粒体的机能丧失有关。研究发现,肥胖、糖尿病等疾病的发生发展过程中均存在线粒体功能的紊乱,并且多种疾病的发生与线粒体DNA的变异有关。因此,为了防止或修复线粒体功能的损伤,寻找靶向线粒体的递药系统越来越重要。针对线粒体的结构特征,该文综述了国内外不同线粒体靶向策略的研究进展。 Mitochondria controls the activation system of apoptosis,a variety of characteristics of tumor cells,including unlimited proliferation ability,unsensitive to the signals of growth inhibition and the damaged apoptosis mechanism,are related to the function loss of mitochondria. Some researches found that the mitochondrial function disorder exists in the occurrence and development of some diseases,such as obesity and diabetes, and the occurrences of many diseases have a relationship with the DNA mutation of mitochondria.Therefore,in order to prevent or repair the damaged function of mitochondrion,looking for the drug delivery systems targeting mitochondria is more and more important. Aiming at the mitochondrial structure characteristics,this paper reviews the research advances in different mitochondrial targeting strategies at home and abroad.
出处 《中国药业》 CAS 2014年第21期1-3,共3页 China Pharmaceuticals
基金 国家863课题 项目编号:2012AA02A603 全军"十一五"重大专项课题 项目编号:06D007
关键词 线粒体 肿瘤 细胞凋亡 mitochondria tumor cell apoptosis
  • 相关文献

参考文献18

  • 1周勇义,郭启华,谷学新.抗癌药物研究动态简介[J].化学教育,2004,25(5):10-13. 被引量:12
  • 2Scaduto RCJr, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives [J]. Biophys J, 1999,76 (1Pt 1): 469.
  • 3Smith RA, Hartley RC, Coeheme HM, et al. Mitoehondrial Pharmacology [ J ]. Trends Pharmacol,2012,33 (6) :341 - 352.
  • 4Smith JC. Potential sensitivemoleeular probes inmembrancs of bioenergetie relevance [ J ]. Bioehim Biophys Aeta, 1990,106 (1) : 1.
  • 5Murphy MP. Selective targeting of bioactive eompoundstomitoehondria [ J ]. Trends Bioteehnol, 1997,15 (8) : 326.
  • 6Rizzuto R, Brini M, De Giorgi F, et al. Double labelling of subeellular structures with organelle-targeted GFP mutantsinvivo[J]. Curr Biol, 1996,6(2): 183.
  • 7马青平,张志文.分子伴娘[J].生物化学与生物物理进展,1992,19(6):409-412. 被引量:2
  • 8Taylor RW, Chinnery PF, Turnbull DM, et al. Selective inhibition of mutant humanmitochondrial DNArepl -ieationinvitro by peptide nucleic acids I J]. Nat Genet, 1997,15 (2) : 212.
  • 9Mueller GM, MeKenzieLR, Homanies GE, et al. Complernentation of de-fective leucine decarboxy lationinf- ibroblasts from amaple syrup urine disease patient by retrovirus-mediatedgene transfer[J]. Gene Ther, 1995,2(7): 461.
  • 10Verma A,Facchina SL,Hirsch DJ,et al. Photodynamictumor therapy: rtti- tochondrial benzodiazepine receptors as a therapeutictargent[J]. Mol Med, 1998,4(1):40.

二级参考文献44

  • 1宝福凯.基因工程癌疫苗研究新进展[J].肿瘤,1995,15(6):479-481. 被引量:1
  • 2常津.具有复合靶向抗癌功能的纳米高分子材料[J].中国生物医学工程学报,1996,15(2):97-101. 被引量:44
  • 3Gogvadze V,Orrenius S,Zhivotovsky B.Mitochondria in cancer cells:what is so special about them[J].Trends Cell Biol,2008,18(4):165-73.
  • 4Kroemer G.Mitochondrial membrane permeabilization in cell death[J].Physiol Rev,2007,87(1):99-163.
  • 5Majewski N,Nogueira V,Bhaskar P,et al.Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak[J].Mol Cell,2004,16 (5):819-30.
  • 6Zamora M,Granell M,Mampel T,et al.Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells[J].Febs Lett,2004,563 (1-3):155-60.
  • 7Don AS,Kisker O,Dilda P,et al.A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells[J].Cancer Cell,2003,3(5):497-509.
  • 8Belzacq AS,El Hamel C,Vieira HL,et al.Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine,arsenite and CD437[J].Oncogene,2001,20(52):7579-87.
  • 9Palmeira CM,Wallace KB.Benzoquinone inhibits the voltage-dependent induction of the mitochondrial permeability transition caused by redox-cycling naphthoquinones[J].Toxicol Appl Pharmacol,1997,143(2):338-47.
  • 10Magda D,Miller RA.Motexafin gadolinium:a novel redox active drug for cancer therapy[J].Semin Cancer Biol,2006,16(6):466-76.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部